Four Application Pillars
Public-safety anti-drug as the breakthrough; vertically extended into healthcare, sports, and the data foundation
Milestones
Lianbao (Yunnan) Health Technology Co., Ltd. was formally established, beginning the journey of spectrum health detection technology R&D.
Proprietary spectrum element analysis core algorithm achieved major progress, with trace element detection precision reaching medical application level.
BC408H palm spectrometer officially entered development phase, with joint research collaborations launched with Tsinghua University and Zhejiang University.
Clinical validation completed at Beijing Tiantan Hospital, Yunnan University Affiliated Hospital and other authoritative institutions, with accuracy exceeding 95%.
Product entered scale commercialization phase, deployed across 30+ city medical institutions and public safety drug screening scenarios nationwide.
Partners
Collaborating with nearly 100 industry partners to build a new digital health ecosystem
Media Coverage
Authoritative media coverage and reports
